Maria Vartiainen

Maria Vartiainen serves as Research Director at the Institute of Biotechnology, University of Helsinki, where she leads groundbreaking research on nuclear organization by actin. She supervises doctoral students in both the Doctoral Programme in Biomedicine and the Doctoral Programme in Integrative Life Science, contributing significantly to the training of next-generation scientists in molecular and cellular biology.

Her research interests focus on the molecular mechanisms of nuclear actin in transcription regulation and gene expression. Vartiainen's work has revealed critical insights into how actin dynamics influence chromatin organization, transcription factor activity, and nuclear architecture. She investigates the roles of actin in MRTF-SRF signaling pathways, nuclear lamina organization, and the regulation of RNA polymerase II during transcription elongation, with implications for understanding both normal cellular processes and disease mechanisms.

Analysis of her recent publications shows a consistent trajectory in understanding nuclear actin's multifaceted roles, with increasing focus on therapeutic applications, particularly in cancer research and viral-host interactions as evidenced by her SARS-CoV-2 hijackome knowledge base project. Her work bridges fundamental cell biology with potential clinical applications.

Scientific Recognition:

• Loreal for Women in Science Award (2014)

Vartiainen has secured substantial research funding from the Academy of Finland, including as Project Manager for the FIRI2024 EuBI HY project (2025-2027) with €1,075,181.30 in funding, and as a key participant in the InterEarth RESET project (2023-2028). She directs the Light Microscopy Technology Platform at the Institute of Biotechnology, providing essential imaging resources for the research community.